Henry Schein, Inc. (NASDAQ:HSIC) – Barrington Research lifted their Q4 2017 earnings per share (EPS) estimates for shares of Henry Schein in a research note issued to investors on Tuesday, according to Zacks Investment Research. Barrington Research analyst M. Petusky now forecasts that the company will post earnings per share of $1.00 for the quarter, up from their previous forecast of $1.00. Barrington Research also issued estimates for Henry Schein’s Q1 2018 earnings at $0.94 EPS.
A number of other equities research analysts also recently weighed in on the company. Credit Suisse Group reissued a “hold” rating and set a $87.50 target price on shares of Henry Schein in a research report on Tuesday, August 29th. Piper Jaffray Companies upgraded shares of Henry Schein from a “neutral” rating to an “overweight” rating in a research note on Friday, September 15th. Morgan Stanley assumed coverage on shares of Henry Schein in a research note on Thursday, September 21st. They set an “equal weight” rating and a $88.00 price target for the company. UBS AG restated a “buy” rating on shares of Henry Schein in a research note on Friday, September 15th. Finally, Stifel Nicolaus restated a “hold” rating and set a $89.00 price target on shares of Henry Schein in a research note on Thursday, October 19th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and seven have given a buy rating to the company. Henry Schein presently has a consensus rating of “Hold” and a consensus target price of $89.88.
WARNING: “Q4 2017 EPS Estimates for Henry Schein, Inc. Lifted by Analyst (HSIC)” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this article on another domain, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this article can be read at https://www.dispatchtribunal.com/2017/11/12/barrington-research-weighs-in-on-henry-schein-inc-s-q4-2017-earnings-hsic.html.
Shares of Henry Schein (NASDAQ HSIC) opened at $67.05 on Thursday. Henry Schein has a 1 year low of $67.02 and a 1 year high of $93.50. The firm has a market capitalization of $10,933.44, a PE ratio of 19.54, a P/E/G ratio of 1.96 and a beta of 1.03. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.85 and a current ratio of 1.55.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.90 by ($0.03). Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The business had revenue of $3.16 billion during the quarter, compared to analyst estimates of $3.05 billion. During the same period in the prior year, the business posted $0.84 earnings per share. The company’s revenue for the quarter was up 10.3% compared to the same quarter last year.
A number of hedge funds have recently bought and sold shares of HSIC. Alecta Pensionsforsakring Omsesidigt raised its position in Henry Schein by 112.0% in the 3rd quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,313,980 shares of the company’s stock worth $435,693,000 after purchasing an additional 2,806,990 shares during the last quarter. Janus Henderson Group PLC raised its position in Henry Schein by 394.1% in the 2nd quarter. Janus Henderson Group PLC now owns 1,465,303 shares of the company’s stock worth $268,173,000 after purchasing an additional 1,168,763 shares during the last quarter. Swedbank raised its position in Henry Schein by 84.9% in the 3rd quarter. Swedbank now owns 2,358,594 shares of the company’s stock worth $193,381,000 after purchasing an additional 1,083,115 shares during the last quarter. Bank of New York Mellon Corp raised its position in Henry Schein by 102.9% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,529,279 shares of the company’s stock worth $125,387,000 after purchasing an additional 775,483 shares during the last quarter. Finally, TimesSquare Capital Management LLC raised its position in Henry Schein by 131.7% in the 3rd quarter. TimesSquare Capital Management LLC now owns 1,082,600 shares of the company’s stock worth $88,762,000 after purchasing an additional 615,300 shares during the last quarter. Hedge funds and other institutional investors own 48.16% of the company’s stock.
In other news, SVP Paul Rose sold 2,126 shares of Henry Schein stock in a transaction that occurred on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total value of $366,756.26. Following the completion of the transaction, the senior vice president now owns 17,841 shares in the company, valued at $3,077,750.91. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.19% of the company’s stock.
Henry Schein declared that its board has authorized a stock repurchase program on Monday, September 18th that authorizes the company to repurchase $400.00 million in shares. This repurchase authorization authorizes the company to buy up to 6.3% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Get a free copy of the Zacks research report on Henry Schein (HSIC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.